AAAAAA

   
Results: 1-2 |
Results: 2
NEU ERBB-2 AMPLIFICATION IDENTIFIES A POOR-PROGNOSIS GROUP OF WOMEN WITH NODE-NEGATIVE BREAST-CANCER/
Authors: ANDRULIS IL BULL SB BLACKSTEIN ME SUTHERLAND D MAK C SIDLOFSKY S PRITZKER KPH HARTWICK RW HANNA W LICKLEY L WILKINSON R QIZILBASH A AMBUS U LIPA M WEIZEL H KATZ A BAIDA M MARIZ S STOIK G DACAMARA P STRONGITHARM D GEDDIE W MCCREADY D
Citation: Il. Andrulis et al., NEU ERBB-2 AMPLIFICATION IDENTIFIES A POOR-PROGNOSIS GROUP OF WOMEN WITH NODE-NEGATIVE BREAST-CANCER/, Journal of clinical oncology, 16(4), 1998, pp. 1340-1349
RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL CHEMOTHERAPY ADDED TO TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH NODE-POSITIVE ESTROGEN AND OR PROGESTERONE RECEPTOR-POSITIVE BREAST-CANCER - A REPORT OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/
Authors: PRITCHARD KI PATERSON AHG FINE S PAUL NA ZEE B SHEPHERD LE ABUZAHRA H RAGAZ J KNOWLING M LEVINE MN VERMA S PERRAULT D WALDE PLD BRAMWELL VHC POLJICAK M BOYD N WARR D NORRIS BD BOWMAN D ARMITAGE GR WEIZEL H BUCKMAN RA
Citation: Ki. Pritchard et al., RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL CHEMOTHERAPY ADDED TO TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH NODE-POSITIVE ESTROGEN AND OR PROGESTERONE RECEPTOR-POSITIVE BREAST-CANCER - A REPORT OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/, Journal of clinical oncology, 15(6), 1997, pp. 2302-2311
Risultati: 1-2 |